Related Experiment Videos
Hot spots for molecular genetic alterations in lung cancer
D M Pitterle1, E M Jolicoeur, G Bepler
1Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.
Abstract:
Lung cancers are a heterogeneous group of tumors broadly classified as small cell or non-small cell lung cancers. In each case, numerous DNA mutations precede tumor formation, resulting in the activation of growth stimulatory genes and the loss of tumor suppressor genes. The known cellular functions of the tumor suppressor genes most commonly affected in lung cancer are reviewed herein, including the retinoblastoma (Rb) gene on chromosome 13q14, the p53 gene on 17p13, and the cyclin-dependent kinase inhibitor (CDKN2) gene on 9p21. The chromosomal locations for other potential tumor suppressor genes are on chromosomes 3p, 9p, and 11p. Candidate genes in these regions include the von Hippel-Lindau (VHL) gene at 3p25, the ubiquitin-activating enzyme homologue (UBE1L at 3p21, the genes for the dinucleoside polyphosphate hydrolase FHIT and receptor protein-tyrosine phosphatase gamma PTPRG at 3p14.2, the genes for tropomyosin beta (TM1) and a talin homologue (talin) at 9p21, and the H-ras gene at 11p15.
Insights
Lung cancer arises from numerous DNA mutations, often affecting key tumor suppressor genes like Rb, p53, and CDKN2. Understanding these genetic alterations is crucial for developing targeted lung cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancers are diverse, categorized as small cell or non-small cell types.
- Tumorigenesis involves DNA mutations leading to growth gene activation and tumor suppressor gene inactivation.
Purpose of the Study:
- To review the cellular functions of commonly mutated tumor suppressor genes in lung cancer.
- To identify chromosomal locations and candidate genes associated with lung cancer development.
Main Methods:
- Literature review of known tumor suppressor genes in lung cancer.
- Identification of chromosomal locations and candidate genes implicated in lung cancer.
Main Results:
- Key tumor suppressor genes affected include retinoblastoma (Rb), p53, and cyclin-dependent kinase inhibitor (CDKN2).
- Other potential tumor suppressor gene locations are identified on chromosomes 3p, 9p, and 11p.
- Candidate genes such as VHL, UBE1L, FHIT, PTPRG, TM1, talin, and H-ras are highlighted.
Conclusions:
- Mutations in specific tumor suppressor genes are fundamental to lung cancer pathogenesis.
- Further research into these candidate genes may reveal novel therapeutic targets for lung cancer.